Azelastine Allergen Chamber - Onset of Action Study

Conditions

• Seasonal Allergic Rhinitis

Interventions

• DRUG: Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
• DRUG: Treatment B: Placebo (Azelastine 0.15% vehicle) nasal spray
• DRUG: Treatment C: Ryaltris (Active Control) - mometasone furoate monohydrate and olopatadine hydrochloride nasal spray

Sponsor

MEDA Pharma GmbH & Co. KG